Obamacare Gives Big Pharma Unfair Advantage: Oif

Dec. 11 (Bloomberg0 -- National Biological Corp.'s Ken Oif comments on the investigation into the technical problems surrounding Healthcare.gov and Obamacare's progress in reaching the uninsured. He speaks with Mark Crumpton on Bloomberg Television's "Bottom Line." (Source: Bloomberg)
Square Rival iZettle Raises $67M From Intel and Zouk
49:50 - Today’s "BWest Byte" is $67 million, for how much iZettle, a Swedish payments startup and rival to Jack Dorsey's Square, has raised from Intel and Zouk. Bloomberg's Matt Miller reports on "Bloomberg West." (Source: Bloomberg)
  • What's Next for Flexible Electronic Technology?
  • Facebook Cracks Down on Video Pirates
  • Deep Dive: Is Market Turmoil Hurting Consumer Sentiment?